Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year ...
Initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in the second quarter of 2025, ...
ITCX serves as guiding light to prominent Hindu temples abroad
Tirupati: The international temples convention and expo (ITCX) aims to help Hindu temples located outside India to adopt some of the best practices in.